KTTA Message Board Post 10039584 | null
home / stock / ktta / ktta message board
Richard646
(investorshub)
Posted on: Aug/11/2022 12:11:46
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169647299
Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating
News, Short Squeeze, Breakout and More Instantly...
Pasithea Therapeutics Corp. Company Name:
KTTA Stock Symbol:
Market:
Pasithea Therapeutics Corp. Website:
-
MIAMI, June 13, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis typ...
-
-- PAS-004 inhibition of in vitro NRAS cell lines does not plateau in contrast to approved MEK inhibitors -- -- PAS-004 inhibition of in vitro NRAS cell lines is greater than selumetinib and binimetinib and similar to trametinib -- -- PAS-004 shows superior activity versus selumetinib and...